Q3 2026 Beyond Air Inc Earnings Call Transcript
Key Points
- Revenue increased by 105% year over year to $2.2 million, indicating strong growth.
- Customer retention exceeds 90%, with more than half under multiyear agreements, showcasing customer satisfaction and stability.
- The company has expanded its global LungFit PH distribution network to 40 countries, enhancing its international presence.
- Significant reduction in operating expenses by 36% year-over-year, demonstrating effective cost management.
- Successful completion of a $5 million financing and a $4.5 million equity financing, providing a cash runway into 2027.
- Net loss attributed to common stockholders was $7.3 million, indicating ongoing financial challenges.
- The sales cycle remains lengthy, typically around 6 to 9 months, which could delay revenue realization.
- The company is still awaiting FDA approval for its second-generation system, which could impact future growth.
- There is uncertainty regarding the translation of efficacy from preclinical to human trials for the NeuroNOS platform.
- The company faces potential challenges in scaling operations and maintaining margins as it transitions to the Gen II system.
Good morning and welcome, everyone, to Beyond Air financial results call for the fiscal quarter ended December 31, 2025. (Operator Instructions)
And now, I would like to turn the call over to Corey Davis of LifeSci Advisors. Please go ahead.
Thank you, operator. Good morning, everyone, and thank you for joining us. Earlier today, we issued a press release announcing the operational highlights and financial results for Beyond Air's third quarter of fiscal 2026 ended December 31, 2025. A copy of this press release can be found on our website, beyondair.net, under the News & Events section.
Before we begin, I would like to remind everyone that we will be making comments and various remarks about future expectations, plans, and prospects, which constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Beyond Air cautions that these forward-looking statements are subject to risks and uncertainties that could cause
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
